激烈的竞争撼动了美国减肥药物格局

The Access Consortium unveils an innovative work-sharing pathway to fast-track priority medical procedures, revolutionizing global healthcare collaboration.

Tryngolza, a novel treatment for familial chylomicronemia syndrome, receives approval from the MHRA in the UK, offering new hope for patients with this rare and debilitating genetic condition.